Skip to main content
. 2019 Aug 31;18:165. doi: 10.1186/s12944-019-1108-2

Table 8.

Clinical Characteristics of TRIB1 rs17321515 A allele Carriers and Non-carriers in the CHD Patients

Parameters Carriers (n = 102) Non-carriers (n = 39) Statistics P value
Male/Female 50/52 20/19 χ2 = 0.058 0.810
Age, y 66.12 ± 9.96 68.10 ± 12.61 t = − 0.883 0.381
BMI, kg/m2 24.22 (22.76, 25.71) 24.51 (22.50, 26.26) Z = − 0.199 0.843
ALT, U/L 18.88 (14.74, 33.03) 20.27 (12.81, 43.41) Z = −0.018 0.985
AST, U/L 22.13 (16.22, 36.05) 22.73 (16.89, 43.23) Z = −0.249 0.803
GGT, U/L 23.64 (17.30, 36.65) 25.98 (16.89, 46.81) Z = −0.350 0.726
ALP, U/L 84.87 (67.18, 110.11) 74.64 (62.40, 108.33) Z = − 0.843 0.399
TG, mmol/L 1.21 (0.90, 1.69) 1.27 (0.92, 1.59) Z = − 0.549 0.583
TC, mmol/L 4.15 (3.59, 5.11) 4.07 (3.68, 5.13) Z = − 0.108 0.914
HDL, mmol/L 0.98 (0.85, 1.16) 1.01 (0.82, 1.25) Z = − 0.904 0.366
LDL, mmol/L 2.49 (2.02, 3.23) 2.30 (2.08, 3.17) Z = − 0.452 0.651
TBIL, umol/L 13.30 (10.67, 17.92) 15.40 (10.60, 18.69) Z = − 0.924 0.355
FPG, mmol/L 5.31 (4.82, 6.43) 4.89 (4.37, 5.55) Z = −2.307 0.021
HHS Vulnerability Disclosure